In head and neck squamous cell carcinoma, RIPK1 expression is downregulated compared to healthy tissues [75], whereas in lung cancer patients and mouse models of lung cancer, RIPK1 expression is markedly elevated in the tumour tissue [76]. This evidence concerns the gene RIPK1 and head and neck squamous cell carcinoma.